The HARS1 gene gives cells instructions for making an enzyme that helps place the amino acid histidine into new proteins. This gene plays an important role in keeping protein building accurate, especially in nerve cells that need steady upkeep. If the gene does not work well, some people develop inherited nerve conditions with weakness, loss of muscle bulk, or reduced feeling in the hands and feet. More disruptive variants can also affect early development and may be linked to developmental delay or seizures.
What is a gene?
Genes are sections of DNA that hold instructions your cells use to make molecules or regulate activities in the body. Some genes carry the code for proteins, the parts that do much of the work inside cells. Other genes mostly help determine when certain processes happen, where they occur, and how strongly they operate. As a whole, genes affect how the body develops and functions, and they can also shape how you respond to food, stress, or medications. If you want to look into this topic more closely, you can read more in the LearnHub.
Overview
HARS1Gene function
What if the gene works
The HARS1 gene helps cells make proteins by attaching the amino acid histidine to its matching transfer RNA. This step supports normal cell function throughout the body, especially in tissues with high energy and protein demands, including nerves.
Risk
What if the gene does not work
Variants in the HARS1 gene can be mild or more severe. Milder changes often cause nerve problems with weakness and numbness in the hands and feet, while more severe variants or changes in both copies can affect hearing and vision.
Treatment
What does that mean for your treatment
For a pathogenic variant in the HARS1 gene, no gene-specific treatment or drug choice is currently established in clinical guidelines. Research is exploring targeted approaches, including amino acid supplementation for some HARS1-related changes, but this remains experimental.
Conditions associated with HARS1
Gene function
What if the gene works
Your cells rely on the HARS1 gene to help turn genetic instructions into proteins. It provides instructions for an enzyme that links the amino acid histidine to its matching transfer RNA, a small carrier used during protein building. This careful step supports normal protein production for everyday growth, repair, and maintenance.
HARS1 gives cells the tool needed to place histidine, one of the building blocks of protein, at the right step. This lets ribosomes (the cell structures that build proteins) keep assembling proteins smoothly.
Its enzyme joins histidine to the matching transfer RNA, a small carrier used during protein building. This helps cells follow genetic instructions in the intended order and supports the HARS1 gene's role in making proteins.
HARS1 mainly works in the cell fluid outside the mitochondria, where many everyday proteins are made. This steady supply supports growth, repair, and routine cell upkeep.
What is a variant?
A genetic variant is a minor change in the DNA sequence within a gene. These changes are common and help make up normal human diversity, such as differences in appearance, metabolism, or how the body responds to environmental factors. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some situations, however, a variant can change how a gene functions more significantly and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Many variants in the HARS1 gene alter the enzyme’s shape, so it cannot attach histidine to transfer RNA efficiently or it becomes unstable and is cleared from the cell. Some changes only partly reduce activity, while more disruptive variants can leave very little working protein and may also disturb how protein copies interact. This shows how HARS1 gene variants affect protein function, and why milder variants may be linked to later, more limited nerve symptoms while stronger ones can cause earlier neurologic disease.
How variants are linked to conditions
Pathogenic variants in the HARS1 gene are best known for causing inherited peripheral nerve conditions, especially Charcot-Marie-Tooth disease type 2W and related distal hereditary motor neuropathy. These diagnoses usually involve slowly progressive weakness and wasting in the lower legs and feet, and sometimes the hands. Rare HARS1 gene variants have also been linked to Usher syndrome type 3B, which combines hearing loss with progressive vision loss.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal feature of human biology. Most do not directly affect health and simply reflect natural differences between people. For many genes, having a variant associated with a condition points to a possible link rather than a definite diagnosis, particularly when several genes and environmental influences play a role. In other situations, though, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the HARS1 gene. In families with a disease-causing HARS1 change, the main factor is whether that genetic change is present, while symptoms can still vary from one person to another.
Inheritance of HARS1 variants
The best-established answer to how HARS1 gene variants are inherited is autosomal dominant. This means a person can have a HARS1-related condition with one altered copy of the gene, and an affected parent can pass that variant to a son or daughter. Each child of a parent carrying the variant has a 50% chance of inheriting it. This pattern applies equally to males and females.
What does my HARS1 result mean for my family?
A disease-causing HARS1 change is most often linked to a dominant inherited nerve condition, so close relatives such as parents, brothers, sisters, and children may also carry the same change. That means it can be relevant for family members who have balance problems, foot changes, hand weakness, or nerve symptoms that were never fully explained. Family testing discussions often focus first on close relatives.
Genetic information
Genetic testing
How you find out about variants
HARS1 genetic testing for variants usually uses a blood or saliva sample, then a lab reads the DNA sequence to look for changes in the HARS1 gene. Results may come from a single gene test, a nerve disease panel, or exome or genome sequencing, depending on the clinical picture.
When should I consider getting a genetic test?
Consider HARS1 testing if there is an unexplained inherited nerve condition, especially slowly worsening weakness, numbness, or balance problems starting in the feet and hands, or a family history of these symptoms. In some families, it may also be considered when hearing and vision loss occur together.
A genetic result is only one part of your health story
A genetic result can be informative, but how much it reveals varies with the condition and the kind of variant involved. Lifestyle, environment, age, and medical history, along with other influences, help shape how the body functions over time. For some conditions, especially those affected by many genes, genetic information offers context rather than certainty and is most useful when viewed alongside other parts of care. In other situations, a genetic result may give a clear answer. In areas like medication response, genetic results can also help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Small differences in genes can change how a drug is absorbed, broken down, or reaches its target, so the same treatment may work better for one person than for another. This is a common part of normal human variation and can influence both how much benefit a medicine gives and how likely side effects are.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way people respond to medications. By looking at relationships between genes and drugs, it helps explain why the same treatment may work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body processes it. This information can support treatment decisions that are more informed and more individualized. More detail on this topic is available in the LearnHub.
Drugs influenced by the HARS1 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines will work. If you have side effects, new symptoms, or worries about how a treatment is affecting you, talk with your doctor or pharmacist.
History
The HARS1 gene entered medical history through two separate lines of research that later came together. In the late 20th century, scientists identified the protein made from this gene as Jo-1, a target of autoantibodies in some people with inflammatory muscle disease and lung involvement. Around the same time, inherited nerve conditions were being mapped more precisely as DNA research improved. Building on this early work, scientists uncovered that variants in the HARS1 gene can underlie some forms of inherited peripheral neuropathy, including Charcot-Marie-Tooth disease. That link helped connect older clinical observations with a specific genetic cause. Over time, HARS1 became recognized in both neurology and autoimmune research, giving it an unusual place in modern medical genetics.